High-Resolution Adaptive Immunity

Our lab uses transcriptomics, single cell analysis and highly-multiplexed peptide assays to generate system-level insights into human adaptive immunity. We have ongoing projects that focus on immunity to viruses, cancer, tuberculosis and alloantigens.

We have also joined the fight against COVID-19 and are currently dissecting the naturally-occurring adaptation of novel and repurposed BCRs and TCRs to recognize SARS-CoV-2.